KAINOS Laboratories, Inc. (4556.T)
JPY 1238.0
(0.73%)
JPY 1238.0
(0.73%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 430.57 Million | 544.51 Million | 604.36 Million | 591.24 Million | 678.18 Million |
| Net Income | 930.06 Million | 845.16 Million | 767.12 Million | 612.8 Million | 398.57 Million |
| Depreciation & Amortization | 118.72 Million | 141.52 Million | 150.14 Million | 142.76 Million | 135.63 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -255.68 Million | -173.94 Million | -100.36 Million | -25.69 Million | 102.45 Million |
| Other non-cash items | -59.61 Million | 28.99 Million | -3.69 Million | 25.22 Million | 249.64 Million |
| Investing Cash Flow | -72.82 Million | -10.32 Million | -141.18 Million | -117.16 Million | -52.2 Million |
| Investments in PPE | -75.7 Million | -7.69 Million | -141.17 Million | -73.19 Million | -55.11 Million |
| Acquisitions | 5.12 Million | 2.93 Million | - | - | - |
| Investment purchases | - | - | - | -45 Million | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -2.24 Million | -5.56 Million | -17 Thousand | 1.03 Million | 2.91 Million |
| Financing Cash Flow | -203.72 Million | -191.13 Million | -31.25 Million | -194.61 Million | 385.76 Million |
| Debt repayment | -50 Million | -40 Million | -20 Million | -37.03 Million | -10.18 Million |
| Dividends payments | -111.17 Million | -111.73 Million | -65.67 Million | -67.29 Million | -59.54 Million |
| Common Stock Repurchased | - | -50 Thousand | -158.1 Million | -90.28 Million | - |
| Common Stock Issuance | - | - | 250.47 Million | - | 435.12 Million |
| Other Financing Activities | -42.55 Million | -1000.00 | -1000.00 | -1000.00 | -1000.00 |
| Accounts receivables | -154.99 Million | -78.38 Million | -123.5 Million | -5.27 Million | 13.45 Million |
| Accounts payables | 80.43 Million | -87.92 Million | 95.83 Million | -55.28 Million | 53.69 Million |
| Inventory | -135.8 Million | -103.28 Million | -94.97 Million | 30.88 Million | -4 Million |
| Other working capital | -104.94 Million | 123.57 Million | 16.53 Million | 26.8 Million | 39.3 Million |
| Cash at beginning of period | 2.67 Billion | 2.33 Billion | 1.9 Billion | 1.62 Billion | 612.76 Million |
| Cash at end of period | 2.83 Billion | 2.67 Billion | 2.33 Billion | 1.9 Billion | 1.62 Billion |
| Capital Expenditure | -75.7 Million | -7.69 Million | -141.17 Million | -73.19 Million | -55.11 Million |
| Effect of forex changes on cash | 12 Thousand | 15 Thousand | 1.09 Million | 50 Thousand | - |
| Net cash flow / Change in cash | 154.03 Million | 343.06 Million | 433.01 Million | 279.52 Million | 1.01 Billion |
| Free Cash Flow | 354.87 Million | 536.81 Million | 463.19 Million | 518.05 Million | 623.06 Million |
| Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2019 FY |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - |
| Net Income | 930.06 Million | 845.16 Million | 767.12 Million | 612.8 Million | 398.57 Million |
| Depreciation & Amortization | 118.72 Million | 141.52 Million | 150.14 Million | 142.76 Million | 135.63 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -255.68 Million | -173.94 Million | -100.36 Million | -25.69 Million | 102.45 Million |
| Other non-cash items | -59.61 Million | 28.99 Million | -3.69 Million | 25.22 Million | 249.64 Million |
| Investing Cash Flow | -72.82 Million | -10.32 Million | -141.18 Million | -117.16 Million | -52.2 Million |
| Investments in PPE | -75.7 Million | -7.69 Million | -141.17 Million | -73.19 Million | -55.11 Million |
| Acquisitions | 5.12 Million | 2.93 Million | - | - | - |
| Investment purchases | - | - | - | -45 Million | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -2.24 Million | -5.56 Million | -17 Thousand | 1.03 Million | 2.91 Million |
| Financing Cash Flow | -203.72 Million | -191.13 Million | -31.25 Million | -194.61 Million | 385.76 Million |
| Debt repayment | -50 Million | -40 Million | -20 Million | -37.03 Million | -10.18 Million |
| Dividends payments | -111.17 Million | -111.73 Million | -65.67 Million | -67.29 Million | -59.54 Million |
| Common Stock Repurchased | - | -50 Thousand | -158.1 Million | -90.28 Million | - |
| Common Stock Issuance | - | - | 250.47 Million | - | 435.12 Million |
| Other Financing Activities | - | -1000.00 | -1000.00 | -1000.00 | -1000.00 |
| Accounts receivables | -154.99 Million | -78.38 Million | -123.5 Million | -5.27 Million | 13.45 Million |
| Accounts payables | 80.43 Million | -87.92 Million | 95.83 Million | -55.28 Million | 53.69 Million |
| Inventory | -135.8 Million | -103.28 Million | -94.97 Million | 30.88 Million | -4 Million |
| Other working capital | -104.94 Million | 123.57 Million | 16.53 Million | 26.8 Million | 39.3 Million |
| Cash at beginning of period | 2.67 Billion | 2.33 Billion | 1.9 Billion | 1.62 Billion | 612.76 Million |
| Cash at end of period | 2.83 Billion | 2.67 Billion | 2.33 Billion | 1.9 Billion | 1.62 Billion |
| Capital Expenditure | -75.7 Million | -7.69 Million | -141.17 Million | -73.19 Million | -55.11 Million |
| Effect of forex changes on cash | 12 Thousand | 15 Thousand | 1.09 Million | 50 Thousand | - |
| Net cash flow / Change in cash | 154.03 Million | 343.06 Million | 433.01 Million | 279.52 Million | 1.01 Billion |
| Free Cash Flow | 354.87 Million | 536.81 Million | 463.19 Million | 518.05 Million | 623.06 Million |
2383
UONE
4671
DANSKE
CRLBF
5276